Professional Documents
Culture Documents
Look at text B –
Note: In some cases, more than one expert may be linked to a summary.
1. Research institutions clearly need outside funding, but at the same time they need
to guard against exploitation by business interests.
2. Only a few business enterprises have made significant financial gain from funding medical research.
3. Governments, businesses, institutions and scientists should all share some blame
for conducting inappropriate scientific research.
4. Scientific research should serve the interests of society as a whole, not just the few.
5. Some drug companies are guilty of promoting medical malpractice by concealing
the results of their funded research.
6. The biotech industry cannot be managed in the same way as other modem
industries.
7. Funding of research is often misdirected in order to suit the aims of business or
government interests.
Model summary:
As funding from businesses is vital for academic research, it is inevitable that commercial
interests and political decisions influence this research. A report
by the Scientists for Global Responsibility (SGR) suggests strongly that these commercial
and political influences can have negative consequences on science.
The problems of commercial influence include 'sponsorship bias' (scientists altering how
they report their results in order to suit the industry that funds them), misleading
messages sent out from industry-funded lobby groups, and the fact that industry is
much more inclined to provide funding for profitable research than for 'blue-sky'
research. Although policy makers argue that commercial influence has a minor impact on
academic research, governments set out to increase competitiveness and are driven by
profit, therefore the public research agenda is set to favour commercial gain more than
anything else.
SGR have made wide-ranging recommendations at all levels to safeguard the
independence of academic, scientific research from commercial pressure and
politically driven influence These recommendations include, more transparency of
funding arrangements, journals to investigate conflicts of interest, ethical standards for
business-university partnerships and more public involvement when setting the research
agenda.